Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A Novel Swarm Intelligence-Driven Feature Selection for Interpretable Machine Learning in Multiparametric MRI-Based GBM Overall Survival Analysis.

Cancers·2026

Same author

Prostate cancer tissue mapping and stratification using DRAQ5 and Eosin fluorescent labels integrated with AI classification and segmentation algorithms.

PloS one·2026

Same author

An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancer.

Nature communications·2026

Same author

Involved Neck Only Versus Mucosal Radiation Therapy for Head and Neck Squamous Cell Cancer of Unknown Primary (HNSCCUP): A National Retrospective Multicenter Cohort Study.

International journal of radiation oncology, biology, physics·2025

Same author

Temporal Validation of an FDG-PET-Radiomic Model for Distant-Relapse-Free-Survival After Radio-Chemotherapy for Pancreatic Adenocarcinoma.

Cancers·2025

Same author

APPROACH: Analysis of Proton versus Photon Radiotherapy in Oligodendroglioma and Assessment of Cognitive Health - study protocol paper for a phase III multicentre, open-label randomised controlled trial.

BMJ open·2025

Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026

Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026

Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026

Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026

Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026

Same journal

Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis.

Cancers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 10, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Reproducible and Interpretable Machine Learning-Based Radiomic Analysis for Overall Survival Prediction in

Abdulkerim Duman¹, Xianfang Sun², Solly Thomas³

¹School of Engineering, Cardiff University, Cardiff CF24 3AA, UK.

|October 16, 2024

Summary

This summary is machine-generated.

A new MRI radiomic model predicts glioblastoma survival. This clinical-radiomic model effectively stratifies patients into low and high-risk groups for overall survival (OS).

Keywords:

clinical applications glioblastoma multiforme machine learning magnetic resonance imaging (MRI)radiomics

More Related Videos

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

Related Experiment Videos

Last Updated: Jun 10, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Combination Radiotherapy in an Orthotopic Mouse Brain Tumor Model

Published on: March 6, 2012

Area of Science:

Radiomics and Medical Imaging
Oncology
Machine Learning in Healthcare

Background:

Glioblastoma multiforme (GBM) is an aggressive brain tumor with poor prognosis.
Accurate prediction of overall survival (OS) is crucial for treatment planning and patient management.
Existing prognostic models often lack precision, necessitating novel predictive tools.

Purpose of the Study:

To develop and validate an MRI-based radiomic model for predicting OS in GBM patients.
To integrate radiomic features with clinical variables for enhanced prognostic accuracy.
To stratify GBM patients into distinct risk groups based on predicted survival.

Main Methods:

Retrospective analysis of pre-treatment MRI scans from 289 GBM patients across multiple institutions.
Extraction and robustness analysis of 660 radiomic features (RFs) from tumor volumes.
Development of a clinical-radiomic model using cross-validation, incorporating age and two robust RFs from T2-FLAIR imaging.

Main Results:

The final model achieved a C-Index of 0.69 (95% CI: 0.62-0.75), demonstrating moderately good discriminatory performance.
Significant patient stratification into low and high-risk groups was achieved (p = 7 × 10^-5) on the validation cohort.
The model achieved the highest integrated area under the curve (iAUC) at 11 months (0.81) compared to existing literature.

Conclusions:

A validated clinical-radiomic model effectively stratifies GBM patients based on OS.
The model utilizes interpretable features, including primary gross tumor volume (GTV) and T2-FLAIR radiomic features.
Future research will explore deep learning-based features for improved OS prediction in GBM.